Treatment of hyperuricemia of neoplastic disease.
D000293:Adolescent; D000328:Adult; D000493:Allopurinol / Q000009:adverse effects / Q000627:therapeutic use; D001769:Blood / Q000378:metabolism; D002675:Child, Preschool; D057487:Enzyme Therapy; D004798:Enzymes / Q000009:adverse effects; D005260:Female; D006402:Hematologic Diseases / Q000188:drug therapy; D006801:Humans; D007938:Leukemia / Q000150:complications*; D008223:Lymphoma / Q000150:complications*; D008297:Male; D014527:Uric Acid / Q000097:blood*; D014969:Xanthine Oxidase / Q000009:adverse effects / Q000627:therapeutic use*
D004798:Enzymes; D014527:Uric Acid; D000493:Allopurinol; D014969:Xanthine Oxidase